Trials / Completed
CompletedNCT02959827
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,320 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iodinated contrast agents | Use of iodine contrast agents and doses following the decision of the treating physician. |
Timeline
- Start date
- 2016-10-15
- Primary completion
- 2017-06-15
- Completion
- 2017-06-15
- First posted
- 2016-11-09
- Last updated
- 2019-01-30
- Results posted
- 2019-01-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02959827. Inclusion in this directory is not an endorsement.